Clinical Trial Update: Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors [NA]

View source ↗

Summary

This completed clinical trial evaluated paclitaxel in combination with CBT-1 for solid tumors, including cervical and ovarian cancers, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Kidney Cancer
• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• CBT-1
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical, Ovarian | NA | Status: COMPLETED | Results posted: 2012-02-06